First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
19 hedge funds and large institutions have $12M invested in First Trust Nasdaq Pharmaceuticals ETF in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20% less capital invested
Capital invested by funds: $15M → $12M (-$3.04M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.24M | |
| 2 | +$1.47M | |
| 3 | +$512K | |
| 4 |
KA
Kovack Advisors
Ft. Lauderdale,
Florida
|
+$237K |
| 5 |
LPL Financial
San Diego,
California
|
+$177K |
Top Sellers
| 1 | -$8.85M | |
| 2 | -$409K | |
| 3 | -$176K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$73.1K |
| 5 |
LGA
Lebenthal Global Advisors
Hauppauge,
New York
|
-$16K |